Collectively, these data highlight the need for a deeper understanding of MR1 biology in the context of cancer and raise the possibility that MR1 polymorphism may need to be considered in the context of allotransplantation and graft vs. host disease (GvHD). The gene discussed is MR1; the disease is cancer.